ClearPoint Neuro, Inc. — Director's Dealing 2024

May 17, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2024-05-16

Reporting Person: Girin Pascal E R (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-16	Restricted Stock Units	$	A	21093	Acquired		Common Stock (21093)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

F2: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders.